๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Gemcitabine increases systemic 5-fluorouracil exposure in advanced cancer patients

โœ Scribed by P. Correale; D. Cerretani; S. Marsili; D. Pozzessere; R. Petrioli; S. Messinese; M. Sabatino; F. Roviello; E. Pinto; G. Francini; G. Giorgi

Book ID
117660095
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
122 KB
Volume
39
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Continuous systemic 5-fluorouracil infus
Continuous systemic 5-fluorouracil infusion in advanced colorectal cancer: Results in 91 patients
โœ R. Hansen; E. Quebbeman; R. Ausman; J. Frick; P. Ritch; W. Schulte; C. Haas; P. ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 411 KB

Ninety-one patients with metastatic colorectal cancer were treated with continuous ambulatory 5-fluorouracil(5FU) infusion 250-300 mg/m2/day through a chronic indwelling central venous catheter. Twenty-six of the 91 patients (29%) had received previous bolus 5FU. Fifty-eight of the 91 patients (64%)